RozanolixizumabUCBmyasthenia gravisgMG
…reatment-emergent adverse events were mild/moderate.Conclusions Rozanolixizumab demonstrated greater improvements in ocular item scores across …
3articles mentioning drugs
13drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Rozanolixizumab ×
Rozanolixizumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning Rozanolixizumab
3 articles · page 1 of 1rozanolixizumabgMGNCT04650854NCT03971422generalised myasthenia gravisMycarinG
…ts with generalised myasthenia gravis (gMG) received one 6-week rozanolixizumab treatment cycle. All patients who enrolled in MG0007 (NCT046508…
rozanolixizumabZilucoplanIVIgNICEplasma exchangegMGPLEX
… support time in England over 5 years.Conclusion Zilucoplan and rozanolixizumab are associated with staff and patient time savings by potential…